Luntz Poll: J&J Pause Gives Americans More Vaccine Confidence

Luntz Poll: J&J Pause Gives Americans More Vaccine Confidence Luntz Poll: J&J Pause Gives Americans More Vaccine Confidence (Dreamstime)

By Eric Mack | Sunday, 18 April 2021 02:01 PM

Americans in a soon-to-be released poll express more confidence in the coronavirus vaccines because of the willingness to pause the distribution of the Johnson & Johnson single-shot dose, according to pollster Frank Luntz.

"We're going to produce a poll [Monday] night — I've seen the data, we're going to release it — that's going to show that the American people are more likely to trust the vaccine because the FDA and the CDC are willing to step in and say, 'Wait a minute, we're not convinced of this, so we want to take a look,'" Luntz told Fox News' "MediaBuzz" on Sunday.

"People are more confident in the vaccine, not less confident, because they know that there are people watching out for them, even if it's only 6 people out of 6.8 million vaccines."

The latter is a reference to the 6 who developed blood clots after taking the 1 dose of the J&J shot.

Even a small amount of adverse reactions might have concerned the U.S. Food and Drug Administration and the Centers for Disease Control, but the caution and the rarity of the reactions actually give Americans polled more confidence and not less in the entire vaccination program for the global coronavirus pandemic, Luntz told host Howard Kurtz.

Also, Luntz added, having doctors make the case for vaccines as former President Donald Trump and President Joe Biden publicly spar over taking credit for the mass vaccinations is "taking the politics out of" the vaccination debate.

Both Trump and Biden should give crediting each other, Luntz told Kurtz.

Luntz, using polling data and interviews with doctors, intends to assist the Biden administration and medical professionals in diminishing vaccine hesitancy, spreading the word on the efficacy and safety of the vaccines, including Johnson & Johnson and the two-shot vaccines of Pfizer and Moderna.

Original Article